Qube Research & Technologies Ltd

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$104,354,262

+$47,676,110 QoQ

Shares Held

426,336

+27.1% QoQ

Ownership

0.814%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#24

of 494 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,018,528 across 169 Biotechnology names. AXSM ranks #5 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc. This page	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$104,354,262	426,336	+27.1%	Shares	Sole	2026-08-14
2026-03-31	$56,678,152	335,334	+3.0%	Shares	Sole	2026-05-15
2025-12-31	$59,438,361	325,440	-0.1%	Shares	Sole	2026-02-17
2025-09-30	$39,547,277	325,626	-16.9%	Shares	Sole	2025-11-14
2025-06-30	$40,880,898	391,617	+38.7%	Shares	Sole	2025-08-14
2025-03-31	$32,933,512	282,376	+81.1%	Shares	Sole	2025-05-15
2024-12-31	$13,191,629	155,911	+413.4%	Shares	Sole	2025-02-14
2024-09-30	$2,729,351	30,370	+1690.7%	Shares	Sole	2024-11-14
2024-03-31	$135,340	1,696	-92.9%	Shares	Sole	2024-05-14
2022-12-31	$1,834,614	23,786	-80.5%	Shares	Sole	2023-02-14
2022-09-30	$5,435,162	121,810	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.